In today's world, Acecarbromal has become a relevant topic for a wide spectrum of society. Since its appearance, Acecarbromal has caused a great impact in different areas, generating discussions, debates and conflicting opinions. Its influence has crossed borders and has aroused the interest of experts on the subject, as well as the population in general. Given its relevance, it is important to analyze in detail and objectively all aspects related to Acecarbromal, understanding its implications, consequences and possible solutions. In this article, we will thoroughly explore the phenomenon of Acecarbromal, from its origins to its current situation, with the aim of providing a complete and enriching perspective on this topic of global interest.
Names | |
---|---|
Preferred IUPAC name
N-(Acetylcarbamoyl)-2-bromo-2-ethylbutanamide | |
Other names
1-Acetyl-3-(2-bromo-2-ethylbutyryl)urea
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.000.953 |
EC Number |
|
KEGG | |
MeSH | acecarbromal |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C9H15BrN2O3 | |
Molar mass | 279.134 g·mol−1 |
Pharmacology | |
Oral | |
Legal status |
|
Related compounds | |
Related compounds
|
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa).
|
Acecarbromal (INN) (brand names Sedamyl, Abasin, Carbased, Paxarel, Sedacetyl, numerous others), also known as acetylcarbromal and acetyladalin, is a hypnotic and sedative drug of the ureide (acylurea) group discovered by Bayer in 1917 that was formerly marketed in the United States and Europe. It is also used in combination with extract of quebracho and vitamin E as a treatment for erectile dysfunction under the brand name Afrodor in Europe. Acecarbromal is structurally related to the barbiturates, which are basically cyclized ureas. Prolonged use is not recommended as it can cause bromine poisoning.